Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Quantification of Serotonin Transporters in Nonhuman Primates Using [123I]ADAM and SPECT

Paul D. Acton, Seok-Rye Choi, Catherine Hou, Karl Plössl and Hank F. Kung
Journal of Nuclear Medicine October 2001, 42 (10) 1556-1562;
Paul D. Acton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seok-Rye Choi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Hou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Plössl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hank F. Kung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Plasma radioactivity as function of time for first 12 min of scan. Shown with total plasma activity is activity after correction for presence of labeled metabolites.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Typical set of time–activity curves for uptake of [123I]ADAM in various regions in brain. CER = cerebellum; MB = midbrain.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Example of graphic analysis of set of time–activity data for midbrain, showing good linearity achieved after t* = 130 min. Axes represent normalized integral of midbrain activity as function of normalized integral of plasma activity.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Correlation between full kinetic model and 2 simplified models for DVRs of midbrain to cerebellum. For reference tissue model, correlation coefficient R2 = 0.94 (P < 0.001), and regression slope = 0.72 ± 0.07. For ratio method, R2 = 0.89 (P < 0.001), and slope = 0.93 ± 0.12.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Parametric image (right), at level of midbrain, obtained by calculating DVR at every pixel using reference tissue model compared against coregistered MR image (left) of same animal.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Determination of optimum time point for measuring ratio of midbrain to cerebellum. Ratios were derived as function of time and compared against full kinetic model result using slope of regression or RMS difference (RMS DIFF) between methods. RMS difference method reaches minimum at roughly same time as slope crosses unity, in range 160–180 min.

Tables

  • Figures
    • View popup
    TABLE 1

    Kinetic Modeling Parameters Derived from Graphic Analysis of [123I]ADAM Uptake in Brain Combined with Metabolite-Corrected Arterial Plasma Data

    ParameterMB t* (min)DV (mL/mL)
    CERMBTHALSTR
    Mean ± SD138  ±  282.25  ±  0.484.86  ±  1.063.83  ±  0.913.53  ±  0.68
    Test–retest (%)13.114.515.514.7
    Intersubject (%)10.411.513.99.6
    ri0.140.400.00.51
    • MB = midbrain; t

    • ↵* = time after which graphic analysis curve becomes linear; CER = cerebellum; THAL = thalamus; STR = striatum; Test–retest = mean absolute difference between each subject’s mean value and each individual value; Intersubject = between-subject variability, calculated same way as Test–retest; ri = intraclass correlation coefficient.

    • View popup
    TABLE 2

    Comparison of DVRs Measured with Full Kinetic Modeling Against Reference Tissue Model and Simple Ratio Technique

    ParameterDVRReference regionRatio
    MBTHALSTRMBTHALSTRMBTHALSTR
    Mean ± SD2.16 ± 0.231.70 ± 0.191.58 ± 0.152.01 ± 0.171.63 ± 0.161.53 ± 0.122.23 ± 0.221.83 ± 0.181.68 ± 0.19
    Test–retest (%)7.73.56.35.42.34.67.63.98.2
    Intersubject (%)5.38.86.85.28.15.46.97.19.8
    ri0.320.460.220.030.640.150.090.400.48
    DVR R20.940.970.950.890.980.93
    DVR slope0.72 ± 0.070.86 ± 0.060.79 ± 0.070.93 ± 0.120.97 ± 0.051.23 ± 0.13
    • MB = midbrain; THAL = thalamus; STR = striatum; Test–retest = mean absolute difference between each subject’s mean value and each individual value; Intersubject = between-subject variability, calculated same way as Test–retest; ri = intraclass correlation coefficient; R2 = correlation coefficient of simplified methods against full kinetic model; slope = gradient of regression between simplified methods of analysis and full kinetic model.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 10
October 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantification of Serotonin Transporters in Nonhuman Primates Using [123I]ADAM and SPECT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quantification of Serotonin Transporters in Nonhuman Primates Using [123I]ADAM and SPECT
Paul D. Acton, Seok-Rye Choi, Catherine Hou, Karl Plössl, Hank F. Kung
Journal of Nuclear Medicine Oct 2001, 42 (10) 1556-1562;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantification of Serotonin Transporters in Nonhuman Primates Using [123I]ADAM and SPECT
Paul D. Acton, Seok-Rye Choi, Catherine Hou, Karl Plössl, Hank F. Kung
Journal of Nuclear Medicine Oct 2001, 42 (10) 1556-1562;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans
  • Optimal Metabolite Curve Fitting for Kinetic Modeling of 11C-WAY-100635
  • Imaging the serotonin transporter during major depressive disorder and antidepressant treatment: 2005 CCNP Young Investigator Award Paper
  • SPECT of Serotonin Transporters Using 123I-ADAM: Optimal Imaging Time After Bolus Injection and Long-Term Test-Retest in Healthy Volunteers
  • 123I-ADAM Binding to Serotonin Transporters in Patients with Major Depression and Healthy Controls: A Preliminary Study
  • Biodistribution and Imaging with 123I-ADAM: A Serotonin Transporter Imaging Agent
  • Characterization of the Binding Sites for 123I-ADAM and the Relationship to the Serotonin Transporter in Rat and Mouse Brains Using Quantitative Autoradiography
  • Molecular Targeting with Radionuclides: State of the Science
  • Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET
  • Pharmacological Characterization of N,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire